- Forums
- ASX - By Stock
- IPD
- Ann: NCCN Guidelines Now Recommend Bioimpedance Spectroscopy
Ann: NCCN Guidelines Now Recommend Bioimpedance Spectroscopy, page-118
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
|
|||||
Last
5.6¢ |
Change
-0.001(0.89%) |
Mkt cap ! $117.3M |
Open | High | Low | Value | Volume |
5.8¢ | 5.8¢ | 5.6¢ | $21.68K | 387.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 424164 | 5.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.6¢ | 91206 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 424164 | 0.055 |
3 | 255555 | 0.054 |
4 | 330710 | 0.053 |
1 | 130000 | 0.052 |
3 | 42222 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.056 | 91206 | 2 |
0.058 | 125188 | 2 |
0.059 | 110002 | 1 |
0.060 | 41689 | 2 |
0.063 | 60166 | 1 |
Last trade - 11.41am 16/08/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online